https://www.selleckchem.com/pr....oducts/Atazanavir.ht
Moreover, ARHGDIB depletion decreased proliferation, migration and invasion of breast cancer cells. Furthermore, we found ARHGDIB mediated epithelial-mesenchymal transition, and MMP2 is the key downstream effector of ARHGDIB. CONCLUSIONS Hence, our results suggested the significance and predictive role of ARHGDIB in breast cancer. High expression of ARHGDIB indicated the poor prognosis for breast cancer patients.BACKGROUND Cancer recurrence for patients with early breast cancer is significant. Patients will benefit from more non-inva